Clinical trial
LORRAINE 2.5/3.5 mm Distal Humerus System - Post-Market Surveillance Study
NCT07774091 is registered in ClinicalTrials.gov with Bonebridge AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- LORRAINE 2.5/3.5 mm Distal Humerus System - Post-Market Surveillance Study
- Lead sponsor
- Bonebridge AG
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- September 30, 2026
- Completion date
- April 30, 2028
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
distal humerus fracture, intra-articular or extra-articular distal humerus fracture